Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reolysin with Carboplatin and Paclitaxel in Pancreatic Cancer
NCT01280058Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2010
- Primary completion
- Jan 2016
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Dec 2010; status: completed.
02
Drugs
pelareorep
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01280058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280058.